ZTS
34
-2
EQT
59
2
ED
39
-4
F
54
-6
OKE
55
5
LB
64
11
UAL
61
4
CPB
40
-4
WDC
68
3
ADM
50
3
FIS
60
-3
C
84
3
BXP
50
-4
ILMN
50
-2
PEG
55
-2
R
80
3
NVDA
70
2
DGX
46
-2
IR
79
2
YUM
45
-4
ZTS
34
-2
EQT
59
2
ED
39
-4
F
54
-6
OKE
55
5
LB
64
11
UAL
61
4
CPB
40
-4
WDC
68
3
ADM
50
3
FIS
60
-3
C
84
3
BXP
50
-4
ILMN
50
-2
PEG
55
-2
R
80
3
NVDA
70
2
DGX
46
-2
IR
79
2
YUM
45
-4
Financhill
Back

ProShares Ultra Gold Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
62

UGL
ProShares Ultra Gold

Last Price:
$129.72
Seasonality Move:
1.33%
Sell
42

SRPT
Sarepta Therapeutics

Last Price:
$35.78
Seasonality Move:
13.8%
Buy
62
ProShares Ultra Gold (UGL) is a Buy

Is ProShares Ultra Gold a Buy, Sell or Hold?

  • The current ProShares Ultra Gold [UGL] share price is $135.51. The Score for UGL is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • UGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $36.20. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UGL Stock Price Chart

What is ProShares Ultra Gold's stock price today?

  • The ProShares Ultra Gold share price today is $135.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UGL is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $36.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

UGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.63 Buy
Relative Strength Index (14 RSI): 48.63 Sell
Chaikin Money Flow: 147576 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (131.47 - 147.01) Sell
Bollinger Bands (100): (99.52 - 132.8) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.97 Sell
Relative Strength Index (14 RSI): 22.77 Sell
Chaikin Money Flow: 421748 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.5 - 62.32) Sell
Bollinger Bands (100): (63.01 - 120.77) Sell

UGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 140.98 Sell
20-day SMA: 141.95 Sell
50-day SMA: 129.36 Buy
200-day SMA: 104.62 Buy
8-day EMA: 139.58 Sell
20-day EMA: 138.76 Sell
50-day EMA: 130.8 Buy
200-day EMA: 107.92 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.5 Sell
20-day SMA: 53.1 Sell
50-day SMA: 67.21 Sell
200-day SMA: 110.18 Sell
8-day EMA: 42.66 Sell
20-day EMA: 50.94 Sell
50-day EMA: 65.94 Sell
200-day EMA: 99.51 Sell

ProShares Ultra Gold Earnings Growth & UGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.81 per share, an increase next quarter of $0.87 per share, a decrease this year of $3.97 per share, and an increase next year of $8.43 per share.

ProShares Ultra Gold Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):